{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.526.3.402",
  "meta": {
    "versionId": "30",
    "lastUpdated": "2023-12-21T17:43:03.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2022-09-09"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.402",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.3.526.3.402"
    }
  ],
  "version": "20220909",
  "name": "InfluenzaVaccineAdministered",
  "title": "Influenza Vaccine Administered",
  "status": "active",
  "experimental": false,
  "date": "2022-09-09T01:02:41-04:00",
  "publisher": "NCQA PHEMUR",
  "expansion": {
    "identifier": "urn:uuid:2981c2c9-a8bf-4800-9eb8-30f256953ac8",
    "timestamp": "2024-10-02T12:31:33-04:00",
    "total": 23,
    "offset": 0,
    "parameter": [
      {
        "name": "count",
        "valueInteger": 1000
      },
      {
        "name": "offset",
        "valueInteger": 0
      }
    ],
    "contains": [
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20240301",
        "code": "86198006",
        "display": "Administration of vaccine product containing only Influenza virus antigen (procedure)"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2024",
        "code": "90630",
        "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, for intradermal use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2024",
        "code": "90653",
        "display": "Influenza vaccine, inactivated (IIV), subunit, adjuvanted, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2024",
        "code": "90654",
        "display": "Influenza virus vaccine, trivalent (IIV3), split virus, preservative-free, for intradermal use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2024",
        "code": "90655",
        "display": "Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2024",
        "code": "90656",
        "display": "Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2024",
        "code": "90657",
        "display": "Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2024",
        "code": "90658",
        "display": "Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2024",
        "code": "90661",
        "display": "Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2024",
        "code": "90662",
        "display": "Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2024",
        "code": "90666",
        "display": "Influenza virus vaccine (IIV), pandemic formulation, split virus, preservative free, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2024",
        "code": "90667",
        "display": "Influenza virus vaccine (IIV), pandemic formulation, split virus, adjuvanted, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2024",
        "code": "90668",
        "display": "Influenza virus vaccine (IIV), pandemic formulation, split virus, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2024",
        "code": "90673",
        "display": "Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2024",
        "code": "90674",
        "display": "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2024",
        "code": "90682",
        "display": "Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2024",
        "code": "90685",
        "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2024",
        "code": "90686",
        "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2024",
        "code": "90687",
        "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2024",
        "code": "90688",
        "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2024",
        "code": "90689",
        "display": "Influenza virus vaccine, quadrivalent (IIV4), inactivated, adjuvanted, preservative free, 0.25 mL dosage, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2024",
        "code": "90694",
        "display": "Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, 0.5 mL dosage, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2024",
        "code": "90756",
        "display": "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use"
      }
    ]
  }
}